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Cortical projection neurons are classified by hodology in corticocortical, commissural
and corticofugal subtypes. Although cortical projection neurons had been regarded
as only glutamatergic neurons, recently corticocortical GABAergic projection neurons
has been also reported in several species. Here, we demonstrate corticofugal
GABAergic projection neurons in the mouse frontal cortex. We employed viral-vector-
mediated anterograde tracing, classical retrograde tracing, and immunohistochemistry
to characterize neocortical GABAergic projection neurons. Injections of the Cre-
dependent adeno-associated virus into glutamate decarboxylase 67 (GAD67)-Cre
knock-in mice revealed neocortical GABAergic projections widely to the forebrain,
including the cerebral cortices, caudate putamen (CPu), ventral pallidum (VP), lateral
globus pallidus (LGP), nucleus accumbens, and olfactory tubercle (Tu). Minor GABAergic
projections were also found in the mediodorsal thalamic nucleus, diagonal band of
Broca, medial globus pallidus, substantial nigra, and dorsal raphe nucleus. Retrograde
tracing studies also demonstrated corticofugal GABAergic projection neurons in the
mouse frontal cortex. Further immunohistochemical screening with neurochemical
markers revealed the majority of corticostriatal GABAergic projection neurons were
positive for somatostatin (SS)-immunoreactivity. In contrast, corticothalamic GABAergic
projection neurons were not identified by representative neurochemical markers for
GABAergic neurons. These findings suggest that corticofugal GABAergic projection
neurons are heterogeneous in terms of their neurochemical properties and target nuclei,
and provide axonal innervations mainly to the nuclei in the basal ganglia.
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INTRODUCTION
The overwhelming majority of long-range corticocortical connections in the cerebral
cortex originate from glutamatergic pyramidal neurons. Recently, several investigations in
rodents, carnivores, and monkeys have provided evidence that a small number of inhibitory
nonpyramidal neurons have long-range corticocortical connections (Peters et al., 1990;
McDonald and Burkhalter, 1993; Tomioka et al., 2005; Tomioka and Rockland, 2007; Higo
et al., 2007, 2009). Although knowledge about corticocortical GABAergic projection neurons
still remains sparse, growing evidence suggests that the vast majority of corticocortical
GABAergic projection neurons are classified as the somatostatin (SS)-expressing neurons
(Tomioka et al., 2005; Tomioka and Rockland, 2007; Higo et al., 2007, 2009; Jinno
et al., 2007; McDonald et al., 2012; Melzer et al., 2012; McDonald and Zaric, 2015a,b).
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This knowledge about corticocortical GABAergic projection
neurons has been most essential to estimate their functional
significance until now (Tamamaki and Tomioka, 2010), since
each GABAergic subpopulation classified by neurochemical
properties would have the same morphological, and
electrophysiological property (Markram et al., 2004; Ascoli
et al., 2008).
Although corticofugal projection neurons had been
considered as glutamatergic pyramidal neurons, two groups
have recently shown that a subset of corticofugal afferents
originates from GABAergic neurons (Jinno and Kosaka,
2004; Lee et al., 2014). Jinno and Kosaka (2004) have
demonstrated that approximately 5% of corticostriatal neurons
are parvalbumin (PV)-expressing GABAergic neurons in
the mouse somatosensory cortex. Lee et al. (2014) have
also found that GABAergic axonal fibers from the medial
frontal cortex widely distribute in various subcortical
regions: the caudate putamen (CPu), nucleus accumbens,
claustrum, and basolateral amygdala. Besides, they have
identified corticofugal GABAergic projection neurons
as PV- or vasoactive intestinal peptide (VIP)-expressing
subpopulations of GABAergic neurons. Those reports
indicate corticofugal GABAergic projection neurons may
be a distinct subpopulation from corticocortical GABAergic
projection neurons because of their different neurochemical
properties.
In this study, in order to examine the anatomical and
neurochemical details of GABAergic projection neurons, we
employed viral-vector-mediated anterograde tracing with
glutamate decarboxylase 67 (GAD67)-Cre knock-in mice,
classical retrograde tracing in GAD67-green fluorescent protein
(GFP) knock-in mice. Improved detection of GABAergic
neurons could provide more in depth characterization of
GABAergic projections neurons in the mouse frontal cortex.
MATERIALS AND METHODS
Animals
All experiments were approved by the Committee for Animal
Experiments of Kumamoto University, and were performed
in accordance with the Guidelines for Use of Animals in
Experiments of Kumamoto University. All efforts were made
to minimize animal suffering and the number of animals used.
Two lines of transgenic mice targeting GABAergic neurons via
GAD67 promoter were used in this study: GAD67-Cre knock-
in mice (Higo et al., 2009) and GAD67-GFP knock-in mice
(Tamamaki et al., 2003).
Producing Anti-mCherry Antibody
We carried out the production of affinity purified anti-
mCherry antibody, as we have previously described in
Tomioka and Rockland (2006). Briefly, the cDNA fragment
encoding the full-length of mCherry was subcloned into the
pGEX-4T2 vector (GE Healthcare; Piscataway, NJ, USA) for
expression of glutathione S-transferase (GST) fusion protein.
GST-mCherry fusion protein was induced in Escherichia
coli by adding isopropyl-1-thio-beta-D-galacto-pyranoside
to the medium. GST-free mCherry were prepared by in-
column thrombin digestion of GST fusion proteins bound to
glutathione–Sepharose 4B media, according to the protocol
recommended by the manufacturer of the GST system (GE
Healthcare). Purified mCherry was emulsified with complete
Freund’s adjuvant (Difco; Detroit, MI, USA) and injected
intracutaneously into two female rabbits (1 mg/animal). Three
weeks after the first immunization, the same amount of mCherry
emulsified with complete Freund’s adjuvant was reinjected into
the rabbits. Additional immunizations were performed every
2 weeks thereafter. After the third immunization, serum was
taken from the rabbits. Antibodies were affinity purified with
mCherry-conjugated Affigel 10 gel (2 mg mCherry/1 ml gel;
BioRad, Richmond, CA, USA). The rabbit serum (1 ml) was
applied to 1 ml of the antigen column, and the specific antibodies
were eluted with 0.1 M glycine-HCl (pH 2.5) and mixed with
1 M potassium phosphate buffer (10:1) to achieve neutral pH.
Antibody was stored at 4◦C with 0.02% NaN3.
Anterograde Labeling of Neocortical
GABAergic Neurons Using the Adeno
Associated Viruses
Two recombinant adeno-associated viruses serotype 5 (AAVs)
were used in this study. One of AAVs, AAV-Ef1a-DIO-
hChR2-mCherry, drives Cre-dependent channel rhodopsin-
fluorescent protein fusion (Sohal et al., 2009), and another
AAV-CAG-GFP drives GFP in various cells such as pyramidal,
nonpyramidal, and glia cells. The GAD67-Cre knock-in mice
(8–12 weeks) were anesthetized by intraperitoneal injection of
chloral hydrate (30 mg/100 g body weight) and placed in a
stereotaxic apparatus. To visualize only GABAergic neurons,
50 nl of AAV-Ef1a-DIO-hChR2-mCherry (1.6 × 10e12) in
110 mM NaCl and 1.56% sorbitol was injected into the frontal
cortex of GAD67-Cre knock-in mice (2.3 mm anterior to the
bregma, 1.5 mm lateral to the midline, and 1.5 mm deep from
the brain surface) by pressure through a glass micropipette.
In some experiments, to visualize both glutamatergic and
GABAergic neurons, 30 nl of a mixture of AAV-CAG-GFP
(1.8 × 10e11/ml) and AAV-Ef1a-DIO-hChR2-mCherry (1.4
× 10e12/ml) in 110 mM NaCl and 1.56% sorbitol was
injected into the frontal cortex of a GAD67-Cre knock-in
mice. The virus-injected mice survived for 3–4 weeks after the
injection.
Retrograde Labeling of Neocortical
GABAergic Neurons Using Fast Blue
The GAD67-GFP knock-in mice (8–12 weeks) were anesthetized
by intraperitoneal injection of chloral hydrate and placed in a
stereotaxic apparatus. Less than 100 nl of 1% Fast Blue solution
(FB; Sigma, St. Louis, MO, USA) dissolved in distilled water was
injected into the ventral part of CPu (0.0 mm anterior to the
bregma, 2.0 mm lateral to the midline, and 4.0 mm deep from
the brain surface), mediodorsal thalamus (1.8 mm posterior to
the bregma, 0.5 mm lateral to the midline, and 3.2 mm deep from
the brain surface), or dorsal raphe nucleus (4.7 mm posterior to
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the bregma, 0.5 mm lateral to the midline, and 2.0 mm deep from
the brain surface) by pressure through a glass micropipette. The
FB-injected mice survived for 5–7 days after the injection.
Fixation
The mice were deeply anesthetized by intraperitoneal injection
of chloral hydrate (100 mg/100 g body weight), and perfused
transcardially with 5 ml of PBS [0.9% (w/v) saline buffered with
5 mM sodium phosphate, pH 7.4], followed by 40 ml of PBS
containing 4% (w/v) formaldehyde. After the mice were left for 2
h, the brains were removed and immersed in 30% sucrose in PBS
overnight for cryoprotection. The brains were cut into 40 µm-
thick frontal sections on a freezing microtome.
Immunoperoxidase Staining for
Anterograde Labeling
In order to enhance the immunoreactivity of anterograde
labeling, we employed the method of combining the avidin
biotinylated peroxidase complex (ABC) method with the
biotinylated tyramine-glucose oxidase amplification in this study
(Kuramoto et al., 2009). Briefly, the free-floating sections were
incubated in PBS containing 0.3% H2O2 for 10 min at room
temperature. After washing in PBS, the sections were blocked in
PBS with 0.3% Triton X-100 (PBS-T) and 1% normal donkey
serum for 1 h at room temperature. This was followed by
overnight incubation with the rabbit anti-mCherry antibody
or the rabbit anti-EGFP antibody in PBS-T containing 1%
normal donkey serum and 0.02% sodium azide (PBS-TSS) at
room temperature. After washing in PBS-T, the sections were
incubated with the biotinylated secondary antibody against
rabbit (1:1000; Millipore, Billerica, MA, USA) in PBS-TSS for
2 h at room temperature. After washing in PBS-T, the sections
were incubated with an ABC (1:200; Vectastain ABC Elite
kit, Vector Laboratories, Burlingame, CA, USA) in PBS at
room temperature for 1 h. After washing in 0.1 M phosphate
buffer (PB; pH 7.4), the sections were incubated for 30 min
in the biotinylated tyramine-glucose oxidase reaction mixture
containing 1.25 µM biotinylated tyramine, 2 mg/ml of glucose
oxidase (Nacalai Tesque, Kyoto, Japan; 259 U/mg), 2 mg/ml
of beta-D-glucose, and 1% BSA in 0.1 M PB. After washing
in PBS, the sections were again incubated for 1 h with an
ABC in PBS. Finally, the bound peroxidase was developed black
by staining with nickel-enhanced coloring solution (0.2 mg/ml
diaminobenzidine, 0.03% H2O2, 0.03% nickel chloride in tris-
buffered saline).
Immunofluorescent Staining
For sections from FB-injected materials, we first took
photomicrographs of all the FB- and GFP-double-labeled cells
in the sections with a ×20 objective under an epifluorescence
microscope BZ-9000 (Keyence, Osaka, Japan). Secondly, we
processed the sections for immunofluorescent staining with
the following antibodies: anti-calretinin (CR) rabbit serum
(Swant, Bellinzona, Switzerland; 1/10,000), anti-neuronal nitric
oxide synthase (nNOS) rabbit IgG (Sigma; 1/2000), anti-
neuropeptide Y (NPY) rabbit serum (Sigma; 1/2000), anti-PV
mouse IgG (Swant; 1/2000 from ascites), anti-SS rabbit affinity
purified polyclonal antibody (Millipore; 1/300), and anti-VIP
rabbit polyclonal antibody (Immunostar, Hudson, WI, USA;
1/400). The sections were incubated with one of the primary
antibodies overnight at room temperature in PBS-TSS. After
washing with PBS-T, the sections were further incubated with
Alexa594-conjugated secondary antibody against rabbit or
mouse IgG (Molecular Probes, Eugene, OR, USA) for 2 h at
room temperature. The sections were mounted onto non-coated
glass slides in PBS. When the FB- and GFP-double-labeled cells
were negative for one of neurochemical markers, the sections
were re-incubated with other neurochemical marker, and then
developed with an Alexa647-conjugated secondary antibody
(Molecular Probes). After immunofluorescent procedures, the
sections were incubated with Hoechst33342 (Wako, Tokyo,
Japan) to identify laminar structures of neocortex (Cx).
For double or triple immunofluorescent staining, some
sections from the AAV injected materials were incubated with
several primary antibodies in PBS-TSS (Table 1), followed by
a mixture of corresponding secondary antibodies of different
fluorescences without cross-reactivity for the other primary
antibodies in individual combinations.
Data Analysis
Immunofluorescence was observed under either an
epifluorescence microscope BZ-9000 or an confocal laser
scanning microscope FV1200 (Olympus, Tokyo, Japan)
with appropriate filter sets for FB (peak excitation, 365 nm;
peak emission, 420 nm), GFP (peak excitation, 488 nm;
peak emission, 509 nm), Alexa594 (peak excitation, 590
nm; peak emission, 617 nm) Alexa647 (peak excitation, 651
nm; peak emission, 667 nm). In the anterograde labeling
experiments, we obtained the integrated images of wide
area of the sections with a ×10 objective using BZ-9000,
according to the manufacturer’s instruction. We took higher
magnification images of individual axons with a ×60 oil
immersion objective using FV1200. In the retrograde labeling
experiments, we scanned sections to find FB- and GFP-double-
labeled neurons with a ×20 objective using BZ-9000. We took
higher magnification images of individual neurons with a
×40 objective using FV1200. The FB fluorescence was often
weakened after the immunohistochemical procedures, although
TABLE 1 | List of primary antibodies.
Antigen Animal Dilution Source
Calretinin Rabbit 1:10000 Swant (7699/4)
GABA Rabbit 1:1000 Sigma (A-2052)
GFP Guinea pig 0.2 µg/ml Dr. Takeshi Kaneko
mRFP Guinea pig 0.2 µg/ml Dr. Takeshi Kaneko
mCherry Rabbit 0.2 µg/ml Raised in our lab
Neuronal NOS Rabbit 1:1000 Sigma (N7280)
Neuropeptide Y Mouse 1:10000 Sigma (N9528)
Parvalbumin Rabbit 1:2000 Swant (McAB235)
Somatostatin Rabbit 1:300 Millipore (AB5494)
Tyrosine hydroxylase Rabbit 1:1000 Millipore (AB152)
Vasoactive intestinal peptide Rabbit 1:400 Immunostar (20077)
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some FB-labeled granules can be detected in the perikarya.
When the FB-fluorescence was completely quenched, we
identified FB- and GFP-double-labeled neurons by carefully
comparing each GFP-labeled cell and its surrounding structures
with those structures in the photomicrographs taken before
immunostaining.
RESULTS
Selective Labeling in Neocortical
GABAergic Neurons
Several previous reports have demonstrated highly specific
expression of Cre recombinase in GAD67-Cre knock-in mice
(Higo et al., 2009; Wu et al., 2011; Saito et al., 2013). However,
no report has examined specific expression of a reporter gene
in neocortical GABAergic neurons using an AAV vector. In
order to ensure selective expression of the reporter gene using
the AAV vector, we first injected the viral mixture (AAV-Ef1a-
DIO-hChR2-mCherry and AAV-CAG-GFP) into the frontal
cortex of GAD67-Cre knock-in mice. The diameters of core
injections were estimated as 0.4–0.6 mm. The injection sites
were confined in frontal cortex, mainly orbitofrontal cortex
(Figure 1). Immunohistochemistry for GFP demonstrated the
structures of pyramidal cells such as thick apical dendrites
and spiny dendrites, and glia cells (Figure 1B). In contrast,
immunohistochemistry for mCherry in the adjacent section
demonstrated only nonpyramidal cells with smooth dendrites
FIGURE 1 | Immunohistochemistry after the injection of viral mixture.
(A) Low magnification lightfield photomicrographs showing green fluorescent
protein (GFP)-immunoreactive cells after the infection of adeno-associated
viruse (AAV)-CAG-GFP. (B) Higher magnification from the rectangle in (A).
Apical dendrites (arrowheads) and the pyramidal cell (arrow) were strongly
visualized by GFP-immunohistochemistry. (C) Low magnification lightfield
photomicrographs of the adjacent section showing mCherry-immunoreactive
cells by the infection of AAV-Ef1a-DIO-hChR2-mCherry. Arrowheads in (A,C)
indicate the same vessels. (D) Higher magnification from the rectangle in (C).
Nonpyramidal neurons were visualized by mCherry-immunohistochemistry.
Note that any features of pyramidal neurons were not identified among the
mCherry-immunoreactive structures. (E) Higher magnification from the arrow
in (D). Monomeric cherry-immunoreactive neurons have smooth dendrites.
Scale bars = 400 µm in (A) (for C); 50 µm in (B,D); 20 µm in (E).
(Figure 1D). Any pyramidal structures like apical dendrites
were not observed in the mCherry-immunoreacted sections.
To further confirm whether mCherry-immunoreactive neurons
are only GABAergic neurons, we examined the co-localization
of GABA-immunoreactivity in mCherry-immunoreactive
neurons. Almost all mCherry-immunoreactive neurons (97%)
exhibited GABA-immunoreactivity (Figure 2), whereas GFP-
immunoreactivity were found mainly in GABA-negative
neurons and occasionally in glia cells. Together, we concluded
that the injection of AAV-Ef1a-DIO-hChR2-mCherry into the
Cx of GAD67-Cre knock-in mice can induce the expression of
hChR2-mCherry in GABAergic neurons, but not glutamatergic
neurons.
Anterograde Labeling of Neocortical
GABAergic Neurons
We next explored the possibility that axonal fibers from
neocortical GABAergic projection neurons may innervate into
several brain regions. In order to visualize axonal fibers of
GABAergic neurons, we injected 50 nl of AAV-Ef1a-DIO-
hChR2-mCherry into the frontal cortex of GAD67-Cre knock-
in mice (n = 18). We confirmed the injection sites were
relatively larger (0.6–1.0 mm) and were confined only in
frontal cortex (Figures 3–5) in 10 mice. These 10 mice
were chosen for further analysis. Neurons labeled by AAV-
Ef1a-DIO-hChR2-mCherry were found within the injection
sites such as the dorsolateral, lateral, and ventral orbital, and
FIGURE 2 | Selective labelings of neocortical GABAergic neurons.
Fluorescent photomicrographs showing GABA-immunoreactivity in
mCherry-immunoreactive neurons. (A) GFP-immunoreactive neurons and
glia-like cells (the arrow) around the injection site. (B–D) Almost all
mCherry-immunoreactive neurons are co-localized with
GABA-immunoreactivity. Scale bar = 50 µm.
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FIGURE 3 | Distribution of axonal fibers form neocortical GABAergic projection neurons in case mRT217. Low (A) and high (B–H) magnification lightfield
photomicrographs showing mCherry-immunoreactive fibers in selected sections after the injection of AAV-Ef1a-DIO-hChR2-mCherry mainly in the orbital cortex (A1).
The mCherry-immunoreactive fibers were found in the dorsal peduncular and infralimbic cortex (A2,B), in the lateral accumbens shell and olfactory tubercle (A3,C),
in the ventral caudate putamen (A4–A7,D–G), in the ventral pallidam (A6,F), in the lateral globus pallidus (A7,G), and in the mediodorsal thalamic nucleus (A8,H).
Note that mCherry-immunoreactive fibers were also found in the contralateral mediodorsal thalamic nucleus. The dashed line indicates the midline of the brain. aca,
anterior commissure, anterior part; acp, anterior commissure, posterior part; CPu, caudate putamen; Cx, neocortex; fmi, forceps minor of the corpus callosum;
ic, internal capsule; LAchSh, lateral accumbens shell; LGP, lateral globus pallidus; LV, lateral ventricle; Tu, olfactory tubercle; VP, ventral pallidum. Scale bars = 1 mm
in (A); 200 µm in (B–H).
primary and secondary motor cortices. In addition, mCherry-
immunoreactive fibers were found throughout the rostral-caudal
extent of the brain. The numbers and intensities of mCherry-
immunoreactive fibers were diverse across animals, presumably
because of the different sizes of injection sites. In contrast,
the patterns of mCherry-immunoreactive fibers were similar
across all animals injected, with some differences (Table 2).
Abundant mCherry-immunoreactive fibers with en passant
synapses were observed in the cerebral cortex, basal ganglia
and thalamus (Figure 6). AdditionallymCherry-immunoreactive
fibers appeared in the amygdala (Figure 6C) in three cases, and
in the dorsal raphe nucleus in one case (Figure 5C). The details
of axonal distribution are briefly summarized below.
In the cerebral cortex, mCherry-immunoreactive fibers were
frequently found in the ipsilateral hemisphere: the insular, dorsal
peduncular, motor, and somatosensory cortices (Table 2). In
two cases (mRT200, 218), the mCherry-immunoreactive fibers
were observed in the parahippocampal regions: presubiculum,
perirhinal and lateral entorhinal cortices. In some cases,
the mCherry-immunoreactive fibers also occurred in the
contralateral hemisphere: the agranular insular, infralimbic,
and orbitofrontal cortices. These axonal fibers were distributed
mainly in layers 1, 2, and 6.
The basal ganglia was the most densely mCherry-
immunoreactive structure across all animals injected
(Figures 3–5; Table 2). Most of labeled fibers formed en
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FIGURE 4 | Distribution of axonal fibers form neocortical GABAergic projection neurons in case mRT218. Low (A) and high (B–F) magnification lightfield
photomicrographs showing mCherry-immunoreactive fibers in selected sections after the injection of AAV-Ef1a-DIO-hChR2-mCherry mainly in the orbital cortex (A1).
The mCherry-immunoreactive fibers were found in the lateral accumbens shell (A2,B), in the ventral CPu (A2–A5,B–E), in the ventral pallidam (A3,C), in the LGP
(A3–A5,C–E), in the basolateral amygdala (A5,E), and in the substantia nigra (A6,F). Note that most of mCherry-immunoreactive fibers appear to travel below the
LGP, although some beaded axonal fibers were also found in the ventral part of LGP. BLA, basolateral amygdaloid nucleus, anterior part; Rt, reticular thalamic
nucleus; SNR, substantia nigra pars reticulata. Scale bars = 1 mm in (A); 200 µm in (B–F).
passant synapses in the anterior part of CPu, but not axonal
bundles as passing fibers. Farther caudally, labeled fibers
were concentrated in the ventral part of both CPu and LGP
(Figures 3D–G, 4C–E, 5B). In addition, labeled fibers were
frequently observed in the medial globus pallidus, accumbens
core and shell, olfactory tubercle (Tu), substantia innominata,
and ventral pallidum (VP; Figures 3, 4 and Table 2), and rarely
in the contralateral CPu and VP (data not shown). It is worth
noting that mCherry-immunoreactive fibers were found in the
substantia nigra in three cases (Figure 4F and Table 2).
In the thalamus, mCherry-immunoreactive fibers were found
occasionally in mediodorsal thalamic nucleus in the four cases,
and very rarely in the contralateral mediodorsal thalamic nucleus
in the case mRT217 (Figure 3H). In two cases (mRT217, 218),
the mCherry-immunoreactive fibers formed en passant synapses
in the reticular thalamic nucleus (Rt; Figure 4E).
In order to discover postsynaptic elements of GABAergic
projection neurons, we carried out double fluorescent stainings
with anti-PV and anti-mCherry antibodies for the nuclei of
basal ganglia and reticular thalamus (Hontanilla et al., 1998; Kita
and Kita, 2001; Miyamoto and Fukuda, 2015), and with anti-
tyrosine hydroxylase (TH) and anti-mCherry antibodies for the
substantia nigra pars compacta. We reconfirmed numerous en
passant synapses on mCherry-immunoreactive fibers in the LGP
where strong PV-immunoreactivity appeared (Figures 3G, 4D,E,
6B,D). Moreover, we found multiple synaptic appositions of
mCherry-immunoreactive fibers on the somata and dendrite of
the PV-immunoreactive neuron (Figure 6D). To our knowledge,
this is the first study suggesting that neocortical neurons
may innervate neurons in the LGP (Gerfen, 2004). Although
en passant synapses on mCherry-immunoreactive fibers were
confirmed in both the Rt and substantia nigra pars compacta, we
could not find any candidates of synaptic appositions on either
PV- or TH- immunoreactive neurons (Figures 6E,H). Further
observations with an electron microscope will be required to
discover postsynaptic elements for those en passant synapses.
Neurochemical Markers of Corticofugal
GABAergic Neurons
We have demonstrated the distribution of axonal fibers from
neocortical GABAergic projection neurons. Since neocortical
GABAergic neurons are classified into subpopulations by
electrophysiological, morphological, and neurochemical
properties (Gonchar and Burkhalter, 1997; Markram et al., 2004;
Ascoli et al., 2008; Kubota et al., 2011; Sohn et al., 2014; Zeisel
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FIGURE 5 | Distribution of axonal fibers form neocortical GABAergic
projection neurons in case mRT210. Low (A) and high (B,C) magnification
lightfield photomicrographs showing mCherry-immunoreactive fibers in
selected sections after the injection of AAV-Ef1a-DIO-hChR2-mCherry mainly
in the orbital cortex (A1). The mCherry-immunoreactive fibers were found in
the LGP (A2,B) and in the dorsal raphe nucleus (A3,C). Scale bars = 1 mm in
(A); 200 µm in (B); 30 µm in (C).
et al., 2015), we next examine which GABAergic subpopulations
project to each brain region. To identify corticofugal GABAergic
neurons, we injected the retrograde tracer FB into several brain
regions: the ventral part of CPu, mediodorsal thalamic nucleus,
or dorsal raphe nucleus.
We injected 100 nl of FB into the ventral part of CPu of
GAD67-GFP knock-in mice (n = 8). We confirmed the injection
sites were mainly confined in the ventral part of CPu and
LGP. Injections of FB into the ventral part of CPu resulted
in numerous FB-labeled neurons mainly in layers 5 and 2/3
of the frontal cortex, consistent with the previous report in
Gabbott et al. (2005), and very occasionally FB- and GFP-double
labeled neurons in the frontal cortex (Figure 7). Interestingly,
FB- and GFP-double-labeled neurons did not mingle with
numerous FB-labeled neurons. Rather FB- and GFP-double-
labeled neurons were found in the regions with sparsely FB-
labeled neurons. The FB- and GFP-double labeled neurons were
observed mainly in infragranular layers, but also in layer 2/3
and the subcortical white matter. Next, we further examined
the neurochemical properties of FB- and GFP-double labeled
neurons using antibodies for CR, nNOS, NPY, PV, SS, and VIP.
Triple labeling demonstrated that most of FB- and GFP-double-
labeled neurons exhibited SS-immunoreactivity (53%: 41/78) or
NPY-immunoreactivity (43%: 6/14). Some of them exhibited
PV-immunoreactivity (7%: 4/61), and none exhibited CR- (0%:
0/14), nNOS- (0%: 0/24), or VIP- (0%: 0/40) immunoreactivity
(Figure 8).
We injected 100 nl of FB into the mediodorsal thalamic
nucleus of GAD67-GFP knock-in mice (n = 13). We confirmed
TABLE 2 | Relative density of GABAergic fibers in various brain structures
from representative injections.
Brain structure 199 200 209 210 217 218 219 222
Dorsal peduncular cortex ++ ++ ++ + ++ +
Medial orbital cortex ++ + ++ ++ ++ ++
Agranular insular cortex + + + ++ + + + +
Granular/Dysgranular insular cortex ++ +
Cingulate cortex + + +
Piriform cortex + + ++ ++
Claustram ++ + + ++ ++ ++ +
Motor cortex ++ + ++ + +
Somatosensory cortex + ++ ++ ++
Basal ganglia
Caudate putamen ++ ++ ++ ++ ++ +++ +++ +++
Nucleus accumbens core + ++ ++
Nucleus accumbens shell + + + ++ ++ ++ ++ +++
Olfactory tubercle + + + ++ +++ ++ + +
Ventral pallidum ++ + + ++ +++ +++ ++ +
Lateral globus pallidus + + ++ ++ + ++
Medial globus pallidus + + ++ ++
Substantial nigra + + +
Septum
Medial septum + + +
Diagonal band of broca + + ++
Thalamus/Epithalamus
Mediodorsal thalamic nucleus + + + +
Centromedial thalamic nucleus + +
Lateral habenular nucleus +
Amygdala
Medial amygdaloid nucleus + +
Anterior amygdaloid area + +
Basolateral amygdala +
Parahippocampal region
Presubiculum +
Lateral entorhinal cortex +
Perirhinal cortex +
Pons
Dorsal raphe nucleus +
the injection sites were mainly confined in the mediodorsal
thalamic nucleus (n = 8). We chose three brain samples for
further analysis after scanning sections under an epifluorescence
microscope, because we could find few FB- and GFP-double
labeled neurons in most samples. Injection of FB into the
mediodorsal thalamic nucleus resulted in numerous FB-labeled
neurons in layer 6 of the frontal cortex, consistent with the
previous report in Gabbott et al. (2005), and very occasionally
FB- and GFP-double labeled neurons in layer 6 (Figure 9).
Although we further examined the neurochemical properties
of FB- and GFP-double labeled neurons, we failed to identify
any neurochemical properties of FB- and GFP-double labeled
neurons (0/24 for CR; 0/21 for PV; 0/23 for SS; 0/17 for VIP).
We injected 100 nl of FB into the dorsal raphe nucleus
of GAD67-GFP knock-in mice (n = 7). We confirmed the
injection sites were mainly in the dorsal raphe nucleus and
superior colliculus. Injection of FB resulted in numerous FB-
labeled neurons in upper layer 5 and lower layer 3 of the frontal
cortex, and occasionally in layer 2 and 6, consistent with the
previous report in Gabbott et al. (2005). Although we made
FB-injection into the dorsal raphe nucleus of 7 GAD67-GFP
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FIGURE 6 | Terminal specializations of corticofugal GABAergic projection. Low (A,F) and high (B–E,G,H) magnification confocal laser scanning images
showing mCherry-immunoreactive fibers (red) after the injection of AAV-Ef1a-DIO-hChR2-mCherry mainly in the orbital cortex. (A–E): parvalbumin
(PV)-immunoreactivity (green) clearly shows the boundaries for the CPu, LGP, and Rt. Monomeric Cherry-immunoreactive fibers were found in the CPu (B),
basolateral amygdala (B,C), LGP (B,D), and Rt (B,E). The terminal specialization are mainly beaded (C–E) and very ocassionally stalked (D,E). Note that
mCherry-immunoreactive fibers established multiple synaptic appositions with the somata and dendrite of the PV-immunoreactive neuron in the LGP (D). (F–G):
Tyrosine hydroxylase (TH)-immunoreactivity (green) clearly shows the distribution of dopaminergic neurons in the substantia nigra pars compacta. The terminal
specialization are mainly beaded in the substantia nigra pars compacta (G). Scale bars = 1 mm in (A,F); 200 µm in (B,G); 20 µm in (C–E,H).
knock-in mice and scanned five frontal sections from each
brain sample, we found only 7 FB- and GFP-double labeled
neurons. Since the number of sections with FB- and GFP-double
labeled neurons was limited, we further tested one neurochemical
property using the antibody for SS. Only one FB- and GFP-
double labeled neuron exhibited SS-immunoreactivity (data not
shown).
Distribution of Axonal Fibers from both
GABAergic and Glutamatergic Neurons
We have confirmed that subpopulations of GABAergic neurons
in the frontal cortex project to ventral part of CPu. Since
glutamatergic neurons in the frontal cortex also project to
the subcortical regions, it is absolutely essential to understand
whether both GABAergic and glutamatergic neurons innervate
the same brain regions. We next examined the axonal trajectories
from both neocortical GABAergic and glutamatergic neurons. In
order to visualize axonal fibers of GABAergic and glutamatergic
neurons, we injected a mixture of AAV-Ef1a-DIO-hChR2-
mCherry and AAV-CAG-GFP into the frontal cortex of GAD67-
Cre knock-in mice.
Numerous GFP-immunoreactive fibers mainly from
neocortical glutamatergic neurons were found throughout the
rostral-caudal extent of CPu. A few mCherry-immunoreactive
fibers from GABAergic neurons were found in the anterior
CPu, whereas many were found in the posterior CPu (data
not shown). Interestingly, mCherry-immunoreactive fibers
were found mainly in the brain regions where a few GFP-
immunoreactive fibers were found. For example, at the level of
the crossing of the anterior commissure, abundant bundles of
GFP-immunoreactive fibers were found in the ventromedial
Frontiers in Neuroanatomy | www.frontiersin.org 8 October 2015 | Volume 9 | Article 133
Tomioka et al. Corticofugal GABAergic projection neurons
FIGURE 7 | Distribution of fast blue (FB)-labeled and FB- and GFP-double-labeled neurons in the cerebral cortex after FB injection into the ventral
part of CPu. Five coronal section outlines illustrating the distribution of retrogradely labeled neurons in the Cx after FB injection into the ventral part of CPu and VP.
One coronal section outline (in the rightmost) showing only the injection site. FB-labeled neurons (blue dots) were found mainly in the insular cortex, and secondary in
the medial prefrontal cortex. FB- and GFP-double-labeled neurons (red dots) were found mainly in the anterior part of frontal cortex. Note that the occurrence of FB-
and GFP-double-labeled neurons is not correlated with the density of FB-labeled neurons. Scale bar = 1 mm.
CPu, while mCherry-immunoreactive fibers were found mainly
in further lateral part of main GFP-immunoreactive area
(Figure 10). Together, GABAergic axonal fibers from the
frontal cortex may innervate into different brain areas from
glutamatergic axonal fibers.
DISCUSSION
We report that a subset of GABAergic neurons in the
mouse frontal cortex project widely to cortical areas and
subcortical nuclei throughout the forebrain and midbrain. They
project primarily to the basal ganglia including the CPu,
VP, LGP, nucleus accumbens, and Tu (Table 2). In some
cases, they also project to the mediodorsal thalamic nucleus,
diagonal band of Broca, medial globus pallidus, substantia
nigra, and dorsal raphe nucleus. In addition, retrograde tracing
experiments also confirm neocortical GABAergic projections to
basal ganglia, thalamic nuclei, and dorsal raphe nucleus. The
majority of corticostriatal GABAergic projection neurons are
SS-positive neurons and some are PV-positive neurons, while
the others are unidentified by representative neurochemical
markers. In addition, corticothalamic GABAergic projection
neurons are also unidentified by representative neurochemical
markers. Together those results indicate that corticofugal
GABAergic projection neurons from the frontal cortex would
consist of several distinct subpopulations of GABAergic
neurons.
Technical Considerations
Although Cre-dependent expression of hChR2-mCherry in
GAD67-Cre knock-in mice labeled nonpyramidal neurons,
a natural concern is whether the apparent labeling could
be specific. We think this concern is unlikely for several
reasons. First, mCherry-immunoreactivity by Cre-dependent
excision were found in nonpyramidal cells, but not in
pyramidal and glia cells. In addition, we confirmed almost
all mCherry-immunoreactive cells were positive for GABA-
immunoreactivity. Second, retrograde tracing experiments were
strongly consistent with the anterograde labeling by Cre-
dependent excision. Third, our results are partly consistent
with the previous report in Lee et al. (2014), which has
described corticofugal GABAergic projection neurons in the
medial frontal cortex. Another potential concern is the sensitivity
of our methods to detect axonal fibers. We took three
methodological improvements to deal with this technical
FIGURE 8 | Fluorescent photomicrographs showing neurochemical
characterization of FB- and GFP-double labeled neurons in the Cx.
Most of FB- and GFP-double labeled neuron were co-labeled with
somatostatin (SS) (A1–A3) and neuropeptide Y (NPY) (B1–B3), and some of
them were with PV (C1–C3), but not with vasoactive intestinal peptide (VIP)
(D1–D3). The arrowheads in each row indicate the same triple- or double
labeled neurons in (A–D). Scale bar = 100 µm in (A) (for B–D).
Frontiers in Neuroanatomy | www.frontiersin.org 9 October 2015 | Volume 9 | Article 133
Tomioka et al. Corticofugal GABAergic projection neurons
FIGURE 9 | Distribution of FB-labeled and FB- and GFP-double-labeled cells in the cerebral cortex after FB injection into the mediodorsal thalamic
nucleus. Four coronal section outlines illustrating the distribution of retrogradely labeled neurons in the Cx after FB injection into the mediodorsal thalamic nucleus.
One coronal section outline (in the rightmost) showing only the injection site. FB-labeled neurons (blue dots) were found mainly in layer 6 of Cx. FB- and
GFP-double-labeled neurons (red dots) were also found in layer 6. Scale bar = 1 mm.
difficulty. First, we chose hChR2-mCherry as a reporter
gene, because it binds the plasma membrane, and may
therefore diffuses faster than cytosolic proteins. Second, relatively
longer survival period after the virus injection allows hChR2-
mCherry to diffuse into axonal fibers even in remote brain
areas. Third, biotinylated tyramine-glucose oxidase amplification
FIGURE 10 | Fluorescent photomicrographs showing the distributions
of GFP- or mCherry-immunoreactive fibers in the ventromedial part of
CPu. Low (A) and high (B–D) magnification confocal laser scanning images
showing mCherry- or GFP-immunoreactive fibers after the injection of
AAV-Ef1a-DIO-hChR2-mCherry and AAV-CAG-GFP into the frontal cortex. No
mCherry-immunoreactive fiber was found in the main trajectory of
GFP-immunoreactive fibers (B). In contrast, some mCherry-immunoreactive
fibers were found in the marginal zone of main trajectory of
GFP-immunoreactive fibers (C,D). The upper, middle, bottom rectangles in (A)
correspond with (C), (B), and (D), respectively. Scale bars = 250 µm in (A); 50
µm in (B) (for C,D).
enhances the mCherry-immunoreactivity. In our pilot study,
we found more enhanced signals and more axonal fibers by
biotinylated tyramine-glucose oxidase amplification than by only
conventional ABC method. Indeed, mCherry-immunoreactive
fibers were found in the remote brain area such as the
dorsal raphe nucleus (Figure 5C). Therefore, our experimental
procedures makes it possible to detect the reporter gene of
the AAVs even in the axonal projection fibers of remote brain
areas.
The volume of viral injection is the primary factor to obtain
strong labeling, especially when the distribution of axonal fibers
is analyzed. In this study, the maximal volume of viral injection
is limited to less than 50 nl, which size is roughly equal
with a 350 µm cube. Considering that an injection solution
is infused into extracellular space, a diameter of injection
would be much larger than 350 µm. Indeed, the diameters
of injection sites are 400–1000 µm in this study, although
we carefully injected a small volume of viral solution several
times for over 30 min in order to deal with this issue. This
technical limitation by a pressure injection could be improved
by a more sophisticated method iontophoresis (Wang et al.,
2014).
In the present study, we demonstrated corticofugal
GABAergic projection neurons qualitatively, since the labeling
efficiency of the viral-vector-mediated anterograde tracer were
variably across animals. This technical limitation would be
general among neuroanatomical tracers. Indeed we carefully
injected the small volume of isosmotic viral solution into the
frontal cortex to avoid any alternation such as tissue damage, but
it was hard to control quality of injection. Recently single cell
labeling techniques (Pinault, 1996; Matsuda et al., 2009) have
succeeded to provide quantitative data like numbers of synaptic
bouton. In near future, quantitative analysis with single cell
labeling techniques will reveal more detailed evidence about the
neural network of corticofugal GABAergic projection neurons.
Previous Studies
Several studies have demonstrated glutamatergic projection
fibers from the rodent frontal cortex to the nuclei throughout
the forebrain and brainstem. In this study, the distribution
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of projection fibers, which are non-selective GFP-labeled
(Figure 10), are mainly consistent with previous reports in
Morino et al. (1994), Zaborszky et al. (1997), Hoover and Vertes
(2011) and Kim and Lee (2012). For example, abundant GFP-
labeled fibers from the frontal cortices were found in the CPu,
VP, mediodorsal thalamic nucleus, and dorsal raphe nucleus, and
occasionally in the cerebral peduncle. Together, the vast majority
of GFP-labeled fibers in the subcortical areas would originate
from neocortical glutamatergic neurons.
Our experiments confirm and extend the recent work
describing GABAergic projection neurons in the medial
prefrontal cortex using Dlxi12b–Cre transgenic mice (Lee et al.,
2014). They injected relatively larger volume of Cre-dependent
AAVs into the medial prefrontal cortex of Dlxi12b–Cre
transgenic mice, and demonstrated GABAergic projection fibers
in the dorsal striatum, nucleus accumbens, claustrum, and
basolateral amygdala. In this study, we also found GABAergic
projection fibers in more various brain regions: mainly in ventral
part of CPu, nucleus accumbens, claustrum, Tu, VP, LGP,
mediodorsal thalamic nucleus and substantia nigra (Table 2).
This is presumably because our method to visualize the reporter
gene may be more sensitive.
In order to examine the neurochemical properties of
GABAergic projection neurons in the prefrontal cortex,
Lee et al. (2014) injected CTB-Alexa488 into the nucleus
accumbens of either PV-IRES-Cre, VIP-IRES-Cre, or SS-
IRES-Cre crossed to TdTomato reporter line (Ai14). They
found retrogradely labeled neurons in 6 of 144, 5 of 100, and
0 of 156 TdTomato-expressing neurons within the medial
prefrontal cortex of PV-IRES-Cre × Ai14, VIP-IRES-Cre ×
Ai14, and SS-IRES-Cre × Ai14 mice, respectively. Considering
that PV-, VIP-, and SS-expressing subpopulations would
constitute the vast majority of GABAergic neurons in the
Cx (Uematsu et al., 2008; Kubota et al., 2011; Sohn et al.,
2014), their results indicate most of GABAergic projection
neurons exhibit either PV- or VIP-immunoreactivity, but
not SS-immunoreactivity. In contrast, we found majority
of GABAergic projection neurons from the frontal cortex
to the ventral part of CPu are SS-immunoreactive neurons,
very occasionally PV-immunoreactive neurons, but not
VIP-immunoreactive neurons. This discrepancy could
be due to several methodological differences between
two studies: first, different retrograde tracers were used.
Second, the retrograde tracers were injected into different
brain regions. Third, the different methods to detect each
GABAergic subpopulation were employed. Indeed we employed
GAD67-GFP knock-in mice to detect GABAergic neurons
and identify GABAergic subpopulations using antibodies
against neurochemical markers. In contrast, Lee et al. (2014)
employed three different knock-in mice to identify GABAergic
subpopulations. In this study, we first detected the general
population of retrogradely labeled GABAergic neurons, and
then examined their neurochemical properties. Therefore,
this approach allows us to conclude which subpopulation
constitutes GABAergic projection neurons. In our conclusion,
the majority of GABAergic projection neurons in the mouse
frontal cortex project to the subcortical areas such as ventral
part of CPu and LGP, and express SS. We also note that a
further systematic study needs to reveal this discrepancy about
neurochemical properties of corticofugal GABAergic projection
neurons.
Circuitry and Functional Significance
Several studies have demonstrated corticocortical GABAergic
projection neurons in rodents, carnivores, and monkeys (Peters
et al., 1990; McDonald and Burkhalter, 1993; Tomioka et al.,
2005; Tomioka and Rockland, 2007; Higo et al., 2007, 2009).
There is increasing evidence that corticocortical GABAergic
projection neurons are relatively homogeneous subpopulation
of GABAergic neurons containing SS (Tomioka et al., 2005;
Tomioka and Rockland, 2007; Higo et al., 2007, 2009; Jinno
et al., 2007; McDonald et al., 2012; Melzer et al., 2012;
Caputi et al., 2013; McDonald and Zaric, 2015a,b) with
some exceptions of GABAergic connections (Miyashita and
Rockland, 2007; Melzer et al., 2012). Especially, we have
demonstrated corticocortical GABAergic projection neurons are
highly homogeneous and are classified as the nNOS-, NPY-,
and SS-expressing subpopulation (Tomioka et al., 2005; Tomioka
and Rockland, 2007). Here, we demonstrate the majority of
corticostriatal GABAergic projection neurons are classified as
the SS-positive and nNOS-negative GABAergic subpopulation,
indicating corticostriatal GABAergic projection neurons may be
distinct from corticocortical GABAergic neurons. Considering
that corticofugal GABAergic projection neurons has been
reported as a subset of PV- or VIP-expressing neurons
(Jinno and Kosaka, 2004; Lee et al., 2014) and we often
failed to identify the neurochemical property of GABAergic
projection neurons, further experiments will be required to
reveal some degree of heterogeneity of GABAergic projection
neurons. Together, corticofugal GABAergic projection neurons
may be distinct from corticocortical projection neurons,
and more heterogeneous from the neurochemical point of
view.
Corticocortical GABAergic projection neurons may account
for 0.5% of the neocortical GABAergic neurons (Tamamaki
and Tomioka, 2010). This speculation is derived from the
neurochemical identity of corticocortical GABAergic projection
neurons. In this study, we could not find a specific neurochemical
marker for corticofugal GABAergic projection neurons, so that
we could not estimate how percentages of neocortical GABAergic
neurons project corticofugally. Instead, we can trace both
corticocortical and corticofugal GABAergic projection fibers
in the anterograde labeling studies. We found the number of
corticofugal GABAergic projection fibers are larger than that of
corticocortical ones across almost all animals injected (Table 2).
This result can not lead to the simple conclusion that corticofugal
GABAergic projection neurons is a larger subpopulation,
because we do not know how dense axonal arborizations
originate from each GABAergic projection neurons. Rather, we
conclude that corticofugal GABAergic projection neurons in the
frontal cortex form much more synapses than corticocortical
ones.
One puzzling observation is that the highly topographical
overlap between corticothalamic GABAergic and glutamatergic
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projection fibers was demonstrated in retrograde labeling
experiments (Figure 8), whereas the partially topographical
overlap in the spatial territories between corticostriatal
GABAergic and glutamatergic projection neurons was shown
by both anterograde and retrograde labeling experiments
(Figures 7, 10). This partially topographical overlap
between GABAergic and glutamatergic projection neurons
has been also observed among corticocortical connections
(Tomioka et al., 2005). Considering that both corticostriatal
and corticocortical GABAergic projection neurons are
subpopulations of somatostatinergic neurons in the Cx,
SS-expressing GABAergic neurons may be embedded in
the unique neuronal network. Indeed, recent reports have
demonstrated that SS-expressing GABAergic neurons show
distinct properties among other GABAergic neurons in the
local circuit (Adesnik et al., 2012; Gentet et al., 2012; Lee
et al., 2012; Pfeffer et al., 2013; Xu et al., 2013; Makino and
Komiyama, 2015; Pinto and Dan, 2015). Here, we demonstrated
corticofugal GABAergic projections, but we did not describe
the neuronal networks where corticofugal GABAergic
projection neurons are embedded. Further experiments to
discover their neuronal networks will reveal the different roles
between corticofugal GABAergic and glutamatergic projection
neurons.
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